Sort
326,823 grants matching “clinical trial”
Immunoprophylactic Strategies to Control Emerging Enteric Infections
$4,973,548Myron Max Levine · University Of Maryland Baltimore · U19 · FY2018 · AI
Johns Hopkins University Trial Innovation Center
$4,972,809Daniel F Hanley · Johns Hopkins University · U24 · FY2023 · TR
Longitudinal Assessment of Post-traumatic Syndromes
$4,969,685Samuel A. McLean · Univ Of North Carolina Chapel Hill · U01 · FY2017 · MH
Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease
$4,967,947Paul S. Aisen · University Of Southern California · R01 · FY2018 · AG
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
$4,966,983Karen C Johnston · University Of Virginia · U01 · FY2014 · NS
Cancer and Leukemia Group B Statistical Center
$4,964,864Duke University · U10 · FY2003 · CA
Office of Cancer Nanotechnology Research
$4,964,781David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease
$4,963,475Eric M Reiman · Banner Health · R01 · FY2024 · AG
Strategy for Improving Stroke Treatment Response (SISTER) Trial
$4,963,344Pooja Khatri · Yale University · UH3 · FY2025 · NS
Biodefense and Emerging Infectious Disease Vaccine Studies
$4,962,764Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
CANCER AND LEUKEMIA GROUP B--STATISTICAL CENTER
$4,962,283Duke University · U10 · FY2002 · CA
NIDCR DIR Clinical Support Services
$4,959,292Janice Lee · National Institute Of Dental & Craniofacial Research · ZID · FY2019 · DE
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
$4,954,929Mirko Paiardini · Emory University · UM1 · FY2021 · AI
Clinical Trials Reporting Porgram (CTRP) Program and Technical Support Services
$4,954,908National Cancer Institute · Y01 · FY2022 · CA
HIV Monoclonal Antibody Studies
$4,954,063Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Pediatric Eye Disease Investigator Group Network
$4,953,324Raymond Kraker · Jaeb Center For Health Research, Inc. · UG1 · FY2019 · EY
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,951,060Richard C. Mohs · Agenebio, Inc. · R01 · FY2018 · AG
Immunoprophylactic Strategies to Control Emerging Enteric Infections
$4,950,326Myron Max Levine · University Of Maryland Baltimore · U19 · FY2015 · AI
PECRB-Research on Type 2 Diabetes Mellitus-Gila River Indian Reservation
$4,950,000National Institute Of Diabetes And Digestive And Kidney Diseases · Y01 · FY2009 · DK
PECRB-Research on Type 2 Diabetes Mellitus-Gila River Indian Reservation
$4,950,000National Institute Of Diabetes And Digestive And Kidney Diseases · Y01 · FY2010 · DK
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,948,571Richard C. Mohs · Agenebio, Inc. · R01 · FY2019 · AG
CAROTID REVASCULARIZATION ENDARTERECTOMY VS STENTING
$4,948,335Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2003 · NS
Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder
$4,947,774Nikej Shah · Nirsum Laboratories, Inc. · U01 · FY2025 · DA
Member Site Core
$4,944,329Peter J O'Dwyer · Ecog-Acrin Medical Research Foundation · U10 · FY2024 · CA
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,942,354Richard C. Mohs · Agenebio, Inc. · R01 · FY2020 · AG